Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Codexis (CDXS) Research & Development (2016 - 2025)

Historic Research & Development for Codexis (CDXS) over the last 16 years, with Q3 2025 value amounting to $13.9 million.

  • Codexis' Research & Development rose 2053.89% to $13.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $52.7 million, marking a year-over-year increase of 1604.92%. This contributed to the annual value of $46.3 million for FY2024, which is 2143.5% down from last year.
  • As of Q3 2025, Codexis' Research & Development stood at $13.9 million, which was up 2053.89% from $13.8 million recorded in Q2 2025.
  • Codexis' Research & Development's 5-year high stood at $21.8 million during Q3 2022, with a 5-year trough of $11.2 million in Q4 2023.
  • In the last 5 years, Codexis' Research & Development had a median value of $13.8 million in 2025 and averaged $14.8 million.
  • In the last 5 years, Codexis' Research & Development surged by 6852.48% in 2022 and then plummeted by 4294.28% in 2023.
  • Over the past 5 years, Codexis' Research & Development (Quarter) stood at $16.4 million in 2021, then increased by 20.37% to $19.7 million in 2022, then crashed by 42.94% to $11.2 million in 2023, then increased by 7.7% to $12.1 million in 2024, then increased by 14.62% to $13.9 million in 2025.
  • Its Research & Development was $13.9 million in Q3 2025, compared to $13.8 million in Q2 2025 and $12.9 million in Q1 2025.